Peter Johnström

5.1k total citations · 2 hit papers
74 papers, 3.4k citations indexed

About

Peter Johnström is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Physiology. According to data from OpenAlex, Peter Johnström has authored 74 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Oncology and 14 papers in Physiology. Recurrent topics in Peter Johnström's work include Medical Imaging Techniques and Applications (22 papers), Lung Cancer Treatments and Mutations (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Peter Johnström is often cited by papers focused on Medical Imaging Techniques and Applications (22 papers), Lung Cancer Treatments and Mutations (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Peter Johnström collaborates with scholars based in Sweden, United Kingdom and United States. Peter Johnström's co-authors include Anthony P. Davenport, John D. Pickard, Tim D. Fryer, Katarina Varnäs, Peter L. Weissberg, James H.F. Rudd, Peter J. Kirkpatrick, Nagui M. Antoun, Elizabeth A. Warburton and Barbara Arch and has published in prestigious journals such as Circulation, NeuroImage and Brain.

In The Last Decade

Peter Johnström

71 papers receiving 3.3k citations

Hit Papers

Imaging Atherosclerotic Plaque Inflammation With [ 18 F]-... 2002 2026 2010 2018 2002 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Imaging Atherosclerotic Plaque Inflammation With [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography
    2002 895 citations Tim D. Fryer, Peter Johnström et al. profile →
  2. Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
    2016 523 citations Peter Ballard, James Yates et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Johnström Sweden 24 1.3k 1.2k 688 620 480 74 3.4k
Samuel Samnick Germany 34 565 0.4× 1.4k 1.2× 974 1.4× 597 1.0× 107 0.2× 131 3.5k
Michael E. Robbins United States 23 667 0.5× 725 0.6× 295 0.4× 736 1.2× 213 0.4× 35 2.3k
Noboru Oriuchi Japan 48 2.2k 1.6× 2.2k 1.9× 1.4k 2.0× 2.1k 3.5× 278 0.6× 230 7.0k
Philip H. Elsinga Netherlands 46 1.2k 0.9× 2.8k 2.4× 1.6k 2.3× 2.1k 3.4× 185 0.4× 247 7.1k
Peter R. Allegrini Switzerland 37 446 0.3× 580 0.5× 622 0.9× 2.8k 4.5× 659 1.4× 75 5.3k
Marc C. Huisman Netherlands 33 438 0.3× 1.9k 1.6× 753 1.1× 403 0.7× 168 0.3× 114 2.9k
Warren D. Foltz Canada 33 408 0.3× 924 0.8× 198 0.3× 635 1.0× 231 0.5× 101 3.0k
María Vidal Spain 28 559 0.4× 527 0.5× 1.2k 1.7× 602 1.0× 295 0.6× 143 2.7k
Barbara J. Fueger Austria 24 796 0.6× 1.1k 1.0× 402 0.6× 585 0.9× 123 0.3× 42 2.5k
Marcus Henze Germany 28 321 0.2× 1.2k 1.0× 779 1.1× 685 1.1× 130 0.3× 64 3.4k

Countries citing papers authored by Peter Johnström

Since Specialization
Citations

This map shows the geographic impact of Peter Johnström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Johnström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Johnström more than expected).

Fields of papers citing papers by Peter Johnström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Johnström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Johnström. The network helps show where Peter Johnström may publish in the future.

Co-authorship network of co-authors of Peter Johnström

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Johnström. A scholar is included among the top collaborators of Peter Johnström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Johnström. Peter Johnström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yinlong, Kenneth Dahl, Peter Johnström, et al.. (2024). Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2. ACS Pharmacology & Translational Science. 7(8). 2414–2423.
2.
Ekman, Simon, Zsolt Cselényi, Andrea Varrone, et al.. (2023). Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study. Clinical and Translational Science. 16(6). 955–965. 7 indexed citations
3.
Ekman, Simon, Andrea Varrone, Aurelija Jučaitė, et al.. (2019). P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases. Journal of Thoracic Oncology. 14(10). S842–S842. 1 indexed citations
4.
Colclough, Nicola, Kan Chen, Peter Johnström, Markus Fridén, & Dermot F. McGinnity. (2019). Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery. Drug Discovery Today. 24(5). 1067–1073. 22 indexed citations
5.
Varnäs, Katarina, Anders Juréus, Sjoerd J. Finnema, et al.. (2018). The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain. Neuropharmacology. 135. 455–463. 12 indexed citations
6.
Ballard, Peter, James Yates, Zhenfan Yang, et al.. (2016). Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity. Clinical Cancer Research. 22(20). 5130–5140. 523 indexed citations breakdown →
7.
Varnäs, Katarina, Anders Juréus, Peter Johnström, et al.. (2016). Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676. Journal of Pharmacology and Experimental Therapeutics. 358(3). 464–471. 4 indexed citations
8.
Johnström, Peter, et al.. (2015). Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing. Nuclear Medicine and Biology. 42(6). 555–560. 21 indexed citations
9.
Schou, Magnus, Katarina Varnäs, Johan Sandell, et al.. (2013). Synthesis, Radiolabeling, and In Vivo Pharmacokinetic Evaluation of the Amyloid Beta Radioligand [11C]AZD4694 in Nonhuman Primates. Molecular Imaging and Biology. 16(2). 173–179. 8 indexed citations
10.
Johnström, Peter, Joseph Bird, & Anthony P. Davenport. (2012). Quantitative Phosphor Imaging Autoradiography of Radioligands for Positron Emission Tomography. Methods in molecular biology. 897. 205–220. 6 indexed citations
11.
Swahn, Britt‐Marie, Johan Sandell, Margareta Bergh, et al.. (2012). Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as 18F-PET imaging agents for β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 22(13). 4332–4337. 19 indexed citations
12.
Johnström, Peter, Tim D. Fryer, Joseph Bird, Hugh K. Richards, & Anthony P. Davenport. (2012). Dynamic In Vivo Imaging of Receptors in Small Animals Using Positron Emission Tomography. Methods in molecular biology. 897. 221–237.
13.
Eriksson, Olof, Peter Johnström, Olle Korsgren, et al.. (2011). Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET. EJNMMI Research. 1(1). 33–33. 34 indexed citations
14.
Juréus, Anders, Britt‐Marie Swahn, Johan Sandell, et al.. (2010). Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand. Journal of Neurochemistry. 114(3). 784–794. 109 indexed citations
15.
Johnström, Peter, Tim D. Fryer, Hugh K. Richards, et al.. (2010). Positron emission tomography of [18F]‐big endothelin‐1 reveals renal excretion but tissue‐specific conversion to [18F]‐endothelin‐1 in lung and liver. British Journal of Pharmacology. 159(4). 812–819. 12 indexed citations
16.
Eriksson, Olof, Peter Johnström, Olle Korsgren, et al.. (2010). In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nuclear Medicine and Biology. 37(3). 357–363. 49 indexed citations
17.
Johnström, Peter, John C. Clark, John D. Pickard, & Anthony P. Davenport. (2008). Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[18F]fluorobenzoate and application to 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography. Nuclear Medicine and Biology. 35(6). 725–731. 24 indexed citations
18.
Laurell, Göran, et al.. (2002). D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hearing Research. 165(1-2). 53–61. 62 indexed citations
19.
Johnström, Peter, Franklin I. Aigbirhio, John C. Clark, et al.. (2000). Syntheses of the First Endothelin-A- and -B-Selective Radioligands for Positron Emission Tomography. Journal of Cardiovascular Pharmacology. 36(5 Suppl 1). S58–S60. 16 indexed citations
20.
Fredriksson, Anna, Peter Johnström, Moustapha Hassan, et al.. (1999). In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants. Life Sciences. 65(2). 165–174. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Samnick Breakdown of academic impact, for papers by Michael E. Robbins Breakdown of academic impact, for papers by Noboru Oriuchi Breakdown of academic impact, for papers by Philip H. Elsinga Breakdown of academic impact, for papers by Peter R. Allegrini Breakdown of academic impact, for papers by Marc C. Huisman Breakdown of academic impact, for papers by Warren D. Foltz Breakdown of academic impact, for papers by María Vidal Breakdown of academic impact, for papers by Barbara J. Fueger Breakdown of academic impact, for papers by Marcus Henze
Rankless by CCL
2026